STOK vs. LASR

Last updated Jun 24, 2026

STOK (Stoke Therapeutics, Inc.) and LASR (nLIGHT, Inc.) are both stocks. STOK operates in Biotechnology (Healthcare), while LASR operates in Semiconductors (Technology). Over the past 5 years, STOK returned -2.95%/yr vs 15.04%/yr for LASR. At a 0.26 correlation, their price movements are largely independent.

Performance

STOK vs. LASR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Stoke Therapeutics, Inc. (STOK) and nLIGHT, Inc. (LASR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, STOK achieves a -1.98% return, which is significantly lower than LASR's 77.13% return.

STOK

• 1D: 0.45%
• 1M: 6.03%
• YTD: -1.98%
• 6M: -2.35%
• 1Y: 168.42%
• 3Y*: 40.95%
• 5Y*: -2.95%
• 10Y*: —

LASR

• 1D: 1.90%
• 1M: -15.41%
• YTD: 77.13%
• 6M: 68.42%
• 1Y: 277.50%
• 3Y*: 63.79%
• 5Y*: 15.04%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

STOK vs. LASR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
STOK Stoke Therapeutics, Inc.	-1.98%	187.76%	109.70%	-43.01%	-61.53%	-61.26%	118.68%	4.08%
LASR nLIGHT, Inc.	77.13%	257.58%	-22.30%	33.14%	-57.66%	-26.65%	61.00%	6.85%

Correlation

The correlation between STOK and LASR is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (All Time) Calculated using the full available price history since Jun 19, 2019	0.26

The correlation between STOK and LASR shifts across timeframes, from 0.12 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap STOK : $1.96B LASR : $3.98B
EPS STOK : -$2.85 LASR : -$0.28
PS Ratio STOK : 57.80 LASR : 12.04
PB Ratio STOK : 4.97 LASR : 9.28
Total Revenue (TTM) STOK : $32.08M LASR : $289.84M
Gross Profit (TTM) STOK : $23.81M LASR : $90.68M
EBITDA (TTM) STOK : -$179.29M LASR : -$3.27M

Return for Risk

STOK vs. LASR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STOK

STOK Risk / Return Rank: 91
STOK Sharpe Ratio Rank: 94
STOK Sortino Ratio Rank: 91
STOK Omega Ratio Rank: 90
STOK Calmar Ratio Rank: 91
STOK Martin Ratio Rank: 92

LASR

LASR Risk / Return Rank: 95
LASR Sharpe Ratio Rank: 97
LASR Sortino Ratio Rank: 92
LASR Omega Ratio Rank: 91
LASR Calmar Ratio Rank: 98
LASR Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STOK vs. LASR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Stoke Therapeutics, Inc. (STOK) and nLIGHT, Inc. (LASR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	STOK	LASR	Difference
Sharpe ratio: Return per unit of total volatility	2.62	3.57	-0.95
Sortino ratio: Return per unit of downside risk	3.24	3.47	-0.22
Omega ratio: Gain probability vs. loss probability	1.40	1.44	-0.04
Calmar ratio: Return relative to maximum drawdown	4.56	10.67	-6.11
Martin ratio: Return relative to average drawdown	12.92	32.70	-19.78

STOK vs. LASR - Sharpe Ratio Comparison

The current STOK Sharpe Ratio is 2.62, which is comparable to the LASR Sharpe Ratio of 3.57. The chart below compares the historical Sharpe Ratios of STOK and LASR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

STOK vs. LASR - Drawdown Comparison

The maximum STOK drawdown since its inception was -95.17%, which is greater than LASR's maximum drawdown of -85.66%. Use the drawdown chart below to compare losses from any high point for STOK and LASR.

Drawdown Indicators

	STOK	LASR	Difference
Max Drawdown Largest peak-to-trough decline	-95.17%	-85.66%	-9.51%
Max Drawdown (1Y) Largest decline over 1 year	-37.16%	-26.19%	-10.97%
Max Drawdown (3Y) Largest decline over 3 years	-71.89%	-58.69%	-13.20%
Max Drawdown (5Y) Largest decline over 5 years	-90.21%	-82.47%	-7.74%
Current Drawdown Current decline from peak	-55.44%	-21.79%	-33.65%
Average Drawdown Average peak-to-trough decline	-62.24%	-52.56%	-9.68%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.09%	8.53%	+4.56%

Volatility

STOK vs. LASR - Volatility Comparison

The current volatility for Stoke Therapeutics, Inc. (STOK) is 12.66%, while nLIGHT, Inc. (LASR) has a volatility of 23.17%. This indicates that STOK experiences smaller price fluctuations and is considered to be less risky than LASR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	STOK	LASR	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.66%	23.17%	-10.51%
Volatility (6M) Calculated over the trailing 6-month period	38.69%	60.90%	-22.21%
Volatility (1Y) Calculated over the trailing 1-year period	64.70%	78.30%	-13.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	80.76%	65.36%	+15.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	80.20%	66.60%	+13.60%

Dividends

STOK vs. LASR - Dividend Comparison

Neither STOK nor LASR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both STOK and LASR in my portfolio?

STOK and LASR have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, STOK or LASR?

LASR has higher volatility (23.17%) compared to STOK (12.66%). In terms of maximum drawdown, STOK dropped -95.17% vs LASR's -85.66%.

Which has better risk-adjusted returns?

LASR currently has the higher Sharpe Ratio (3.57 vs 2.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.